'Glenmark's nasal spray can cut covid viral load by 99%

Drugmaker and its Canadian partner SaNOtize on Wednesday said that the nitric oxide nasal spray (NONS) has met the key endpoints and demonstrated reduction of Covid viral load by 93.7% in 24 hours and 99% in 48 hours in the phase-3 clinical trials conducted in India. The randomised, double-blind phase 3 trial was conducted by Glenmark in 306 vaccinated and non-vaccinated adults of symptomatic mild Covid-19 across 20 clinical sites in India during Delta and Omicron waves.